AbbVie

AbbVie is a global biopharmaceutical company that focuses on researching and developing advanced therapies for complex diseases. Founded in 2013 as a spin-off from Abbott Laboratories, it specializes in fields such as immunology, oncology, and neuroscience. AbbVie is known for its flagship drug, Humira, which treats autoimmune conditions. The company aims to improve patient outcomes by investing in innovative treatments and conducting extensive clinical research. With a strong commitment to science and health, AbbVie plays a significant role in advancing medical care and addressing unmet medical needs worldwide.